Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future?
作者信息
Ganie M Ashraf, Kalra Sanjay
机构信息
Department of Endocrinology, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India.
出版信息
Indian J Endocrinol Metab. 2011 Oct;15(4):239-41. doi: 10.4103/2230-8210.85571.
Abstract
摘要
相似文献
1
Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future?多囊卵巢综合征——一种代谢性疾病，女性所有生活方式紊乱问题的根源——印度的医疗预算未来能否应对这一问题？
Indian J Endocrinol Metab. 2011 Oct;15(4):239-41. doi: 10.4103/2230-8210.85571.
2
Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.多囊卵巢综合征女性中代谢综合征及其组分的患病率存在种族和民族差异：一项区域性横断面研究。
Am J Obstet Gynecol. 2017 Aug;217(2):189.e1-189.e8. doi: 10.1016/j.ajog.2017.04.007. Epub 2017 Apr 8.
3
Lifestyle and pregnancy complications in polycystic ovary syndrome: The SCOPE cohort study.多囊卵巢综合征患者的生活方式与妊娠并发症：SCOPE 队列研究。
Clin Endocrinol (Oxf). 2019 Jun;90(6):814-821. doi: 10.1111/cen.13954. Epub 2019 Apr 1.
4
Does the risk of metabolic disorders increase among women with polycystic ovary morphology? A population-based study.多囊卵巢形态的女性患代谢紊乱的风险会增加吗？一项基于人群的研究。
Hum Reprod. 2016 Jun;31(6):1339-46. doi: 10.1093/humrep/dew071. Epub 2016 Apr 12.
5
Targets to treat metabolic syndrome in polycystic ovary syndrome.多囊卵巢综合征中代谢综合征的治疗靶点。
Expert Opin Ther Targets. 2015;19(11):1561-74. doi: 10.1517/14728222.2015.1101067. Epub 2015 Oct 21.
6
[Women with polycystric ovary syndrome have a higher frequency of metabolic syndrome regardless of body mass index].无论体重指数如何，患有多囊卵巢综合征的女性患代谢综合征的频率更高。
Rev Bras Ginecol Obstet. 2012 Jan;34(1):4-10.
7
Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.代谢综合征及肥胖与多囊卵巢综合征的关系：一项基于人群的对照研究。
Am J Obstet Gynecol. 2001 Feb;184(3):289-96. doi: 10.1067/mob.2001.109596.
8
Insulin resistance and the long-term consequences of polycystic ovary syndrome.胰岛素抵抗与多囊卵巢综合征的长期后果
J Obstet Gynaecol. 2011;31(2):105-10. doi: 10.3109/01443615.2010.539722.
9
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).印度患有多囊卵巢综合征（PCOS）的青春期女性的高敏C反应蛋白（hs-CRP）水平及其与多囊卵巢综合征各组分的关系。
Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.
10
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.系统评价：多囊卵巢综合征与代谢综合征和非酒精性脂肪性肝病的关系。
Aliment Pharmacol Ther. 2011 Apr;33(7):801-14. doi: 10.1111/j.1365-2036.2011.04579.x. Epub 2011 Jan 20.
引用本文的文献
1
Association Between Serum Antinuclear Antibody and Polycystic Ovarian Syndrome in Reproductive Women Aged 18 to 35 Years: A Quest for an Autoimmune Marker.18至35岁育龄女性血清抗核抗体与多囊卵巢综合征的关联：寻找自身免疫标志物
Cureus. 2024 Dec 6;16(12):e75224. doi: 10.7759/cureus.75224. eCollection 2024 Dec.
2
Primary Care Screening Tool for Polycystic Ovary Syndrome: Step One in the Battle Against Non-Communicable Disease.多囊卵巢综合征的初级保健筛查工具：对抗非传染性疾病的第一步。
Indian J Endocrinol Metab. 2023 Mar-Apr;27(2):105-106. doi: 10.4103/ijem.ijem_333_22. Epub 2023 Apr 14.
3
Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.LHCGR 基因变异（rs2293275）对多囊卵巢综合征患者临床生化特征及黄体生成素水平的影响修饰作用。
Biochem Genet. 2023 Aug;61(4):1418-1432. doi: 10.1007/s10528-022-10327-z. Epub 2023 Jan 12.
4
Barriers to treatment regimen adherence in Indian women with polycystic ovarian syndrome.印度多囊卵巢综合征女性治疗方案依从性的障碍
J Family Med Prim Care. 2022 Jul;11(7):3687-3692. doi: 10.4103/jfmpc.jfmpc_2360_21. Epub 2022 Jul 22.
5
Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study.黄连素、肌醇和二甲双胍对多囊卵巢综合征女性影响的研究：一项前瞻性随机研究。
Cureus. 2022 Jan 31;14(1):e21781. doi: 10.7759/cureus.21781. eCollection 2022 Jan.
6
Idiopathic Hyperprolactinemia Presenting as Polycystic Ovary Syndrome in Identical Twin Sisters: A Case Report and Literature Review.同卵双胞胎姐妹中表现为多囊卵巢综合征的特发性高催乳素血症：一例报告及文献综述
Cureus. 2018 Jul 19;10(7):e3004. doi: 10.7759/cureus.3004.
7
Influence of PCOS in Obese vs. Non-Obese women from Mesenchymal Progenitors Stem Cells and Other Endometrial Cells: An in silico biomarker discovery.多囊卵巢综合征对肥胖与非肥胖女性间充质祖细胞及其他子宫内膜细胞的影响：一项计算机模拟生物标志物发现研究
Bioinformation. 2017 Apr 30;13(4):111-115. doi: 10.6026/97320630013111. eCollection 2017.
8
Polycystic Ovary Syndrome May Be an Autoimmune Disorder.多囊卵巢综合征可能是一种自身免疫性疾病。
Scientifica (Cairo). 2016;2016:4071735. doi: 10.1155/2016/4071735. Epub 2016 May 5.
9
A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India.印度孟买青少年和年轻女孩多囊卵巢综合征的横断面研究。
Indian J Endocrinol Metab. 2014 May;18(3):317-24. doi: 10.4103/2230-8210.131162.
10
Academic endocrinology in India: Forty, fifteen or both?印度的学术内分泌学：四十、十五还是两者兼具？
Indian J Endocrinol Metab. 2011 Oct;15(4):237-8. doi: 10.4103/2230-8210.85570.
本文引用的文献
1
Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation.多囊卵巢综合征中的焦虑和抑郁：全面调查。
Fertil Steril. 2010 May 1;93(7):2421-3. doi: 10.1016/j.fertnstert.2009.09.018. Epub 2010 Feb 1.
2
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.在对比不同诊断标准的情况下，对社区样本中多囊卵巢综合征的流行情况进行评估。
Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12.
3
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物（二甲双胍、罗格列酮、吡格列酮、D-手性肌醇）
Cochrane Database Syst Rev. 2009 Oct 7(4):CD003053. doi: 10.1002/14651858.CD003053.pub3.
4
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.多囊卵巢综合征生殖表型的代谢特征
Hum Reprod Update. 2009 Jul-Aug;15(4):477-88. doi: 10.1093/humupd/dmp008. Epub 2009 Mar 11.
5
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.有月经不规律病史且雄激素测量值升高的绝经后女性发生心血管无事件生存期恶化的风险较高：美国国立卫生研究院——国立心肺血液研究所资助的女性缺血综合征评估结果
J Clin Endocrinol Metab. 2008 Apr;93(4):1276-84. doi: 10.1210/jc.2007-0425. Epub 2008 Jan 8.
6
Molecular mechanisms of insulin resistance in polycystic ovary syndrome.多囊卵巢综合征中胰岛素抵抗的分子机制
Trends Mol Med. 2006 Jul;12(7):324-32. doi: 10.1016/j.molmed.2006.05.006.
7
Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.卵巢甾体激素调节多囊卵巢综合征中的神经内分泌功能障碍。
J Endocrinol Invest. 2005 Nov;28(10):882-92. doi: 10.1007/BF03345319.
8
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.多囊卵巢综合征在生育期与医疗保健相关的经济负担。
J Clin Endocrinol Metab. 2005 Aug;90(8):4650-8. doi: 10.1210/jc.2005-0628. Epub 2005 Jun 8.
9
Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.螺内酯与二甲双胍治疗多囊卵巢综合征的疗效比较：一项开放标签研究。
J Clin Endocrinol Metab. 2004 Jun;89(6):2756-62. doi: 10.1210/jc.2003-031780.
10
The prevalence and features of the polycystic ovary syndrome in an unselected population.未选择人群中多囊卵巢综合征的患病率及特征
J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9. doi: 10.1210/jc.2003-032046.
Zotero 插件